United States
Germany
Japan
United Kingdom
China
APOPT1 (Myc-DDK-tagged)-Human chromosome 14 open reading frame 153 (C14orf153)
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
Products
APOPT1 (tGFP-tagged) - Human chromosome 14 open reading frame 153 (C14orf153)
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
Lenti ORF clone of Human chromosome 14 open reading frame 153 (C14orf153), mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
Lenti ORF clone of Human chromosome 14 open reading frame 153 (C14orf153), Myc-DDK-tagged
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
- LentiORF®
Purified recombinant protein of Human chromosome 14 open reading frame 153 (C14orf153), full length, with N-terminal HIS tag, expressed in E. coli, 50ug
| Tag | N-His |
| Expression Host | E. coli |
APOPT1 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression lysate of chromosome 14 open reading frame 153 (C14orf153)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
APOPT1 (untagged)-Human chromosome 14 open reading frame 153 (C14orf153)
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-XL6 |
qPCR primer pairs and template standards against Homo sapiens gene C14orf153
| Application | Plasmid of exact quantity for transcript copy number calculation |
APOPT1 (untagged)-Human chromosome 14 open reading frame 153 (C14orf153)
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
3' UTR clone of chromosome 14 open reading frame 153 (C14orf153) for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
qSTAR qPCR primer pairs against Homo sapiens gene APOPT1
Transient overexpression of APOPT1 in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
